Han de Vries1, Hareld M C Kemps2, Mariette M van Engen-Verheul3, Roderik A Kraaijenhagen4, Niels Peek5. 1. Actuarial Department, Achmea Zorg en Gezondheid, Leiden, The Netherlands Research for Decisions, Utrecht, The Netherlands. 2. Department of Cardiology, Máxima Medical Centre, Veldhoven, The Netherlands. 3. Department of Medical Informatics, Academic Medical Center/University of Amsterdam, Room number J1b-110, PO 22660, Amsterdam 1100 DD, The Netherlands. 4. NIPED (Netherlands Institute for Prevention and E-Health Development) Research Foundation, Amsterdam CardioVitaal Cardiac Rehabilitation Center, Amsterdam. 5. Department of Medical Informatics, Academic Medical Center/University of Amsterdam, Room number J1b-110, PO 22660, Amsterdam 1100 DD, The Netherlands MRC Health e-Research Centre, Institute of Population Health, University of Manchester, UK n.b.peek@amc.uva.nl.
Abstract
AIMS: To assess the effects of multi-disciplinary cardiac rehabilitation (CR) on survival in the full population of patients with an acute coronary syndrome (ACS) and patients that underwent coronary revascularization and/or heart valve surgery. METHODS AND RESULTS: Population-based cohort study in the Netherlands using insurance claims database covering ∼22% of the Dutch population (3.3 million persons). All patients with an ACS with or without ST elevation, and patients who underwent coronary revascularization and/or valve surgery in the period 2007-10 were included. Patients were categorized as having received CR when an insurance claim for CR was made within the first 180 days after the cardiac event or revascularization. The primary outcome was survival time from the inclusion date, limited to a total follow-up period of 4 years, with a minimum of 180 days. Propensity score weighting was used to control for confounding by indication. Among 35 919 patients with an ACS and/or coronary revascularization or valve surgery, 11 014 (30.7%) received CR. After propensity score weighting, the adjusted hazard ratio (HR) associated with receiving CR was 0.65 (95% CI 0.56-0.77). The largest benefit was observed for patients who underwent coronary artery bypass grafting (CABG) and/or valve surgery (HR = 0.55, 95% CI 0.42-0.74). CONCLUSION: In a large and representative community cohort of Dutch patients with an ACS and/or intervention, CR was associated with a substantial survival benefit up to 4 years. This survival benefit was present regardless of age, type of diagnosis, and type of intervention. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: To assess the effects of multi-disciplinary cardiac rehabilitation (CR) on survival in the full population of patients with an acute coronary syndrome (ACS) and patients that underwent coronary revascularization and/or heart valve surgery. METHODS AND RESULTS: Population-based cohort study in the Netherlands using insurance claims database covering ∼22% of the Dutch population (3.3 million persons). All patients with an ACS with or without ST elevation, and patients who underwent coronary revascularization and/or valve surgery in the period 2007-10 were included. Patients were categorized as having received CR when an insurance claim for CR was made within the first 180 days after the cardiac event or revascularization. The primary outcome was survival time from the inclusion date, limited to a total follow-up period of 4 years, with a minimum of 180 days. Propensity score weighting was used to control for confounding by indication. Among 35 919 patients with an ACS and/or coronary revascularization or valve surgery, 11 014 (30.7%) received CR. After propensity score weighting, the adjusted hazard ratio (HR) associated with receiving CR was 0.65 (95% CI 0.56-0.77). The largest benefit was observed for patients who underwent coronary artery bypass grafting (CABG) and/or valve surgery (HR = 0.55, 95% CI 0.42-0.74). CONCLUSION: In a large and representative community cohort of Dutch patients with an ACS and/or intervention, CR was associated with a substantial survival benefit up to 4 years. This survival benefit was present regardless of age, type of diagnosis, and type of intervention. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Quinn R Pack; Brian D Lahr; Ray W Squires; Francisco Lopez-Jimenez; Kevin L Greason; Hector I Michelena; Kashish Goel; Randal J Thomas Journal: Am J Cardiol Date: 2016-04-05 Impact factor: 2.778
Authors: Wouter T Gude; Mariëtte M van Engen-Verheul; Sabine N van der Veer; Hareld M C Kemps; Monique W M Jaspers; Nicolette F de Keizer; Niels Peek Journal: Implement Sci Date: 2016-12-09 Impact factor: 7.327
Authors: M Sunamura; N Ter Hoeve; M L Geleijnse; R V Steenaard; H J G van den Berg-Emons; H Boersma; R T van Domburg Journal: Neth Heart J Date: 2017-11 Impact factor: 2.380